Tudor Investment Corporation »

Vistagen Therapeutics Ord shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $61k 106k 0.57
2025-12-31 $50k 76k 0.66

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Microsoft Corp - US Equity (MSFT)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Tesla Inc - US Equity (TSLA)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Meta Platforms Inc - US Equity (META)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Alibaba Group Holding Ltd - US Depository Receipt (BABA)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Vistagen Therapeutics Ord

OrbiMed Advisors
TCG Crossover Management
Vanguard Group
Vanguard Capital Management
ADAR1 Capital Management
Millennium Management
Stempoint Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Geode Capital Management
BlackRock
Luminus Management
Jane Street
Renaissance Technologies

View all funds holding Vistagen Therapeutics Ord